SEC Form 4 · accession 0001225208-15-005240
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine M. Szyman
Officer — CVP, Critical Care & Vascular
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2015 | A | 12,340 | $0.00 | A | 12,340 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire)F2 | $133.72 | Feb 19, 2015 | A | 14,285 | A | Feb 19, 2016 | Feb 18, 2022 | Common Stock | 14,285 | 14,285 | D |
Explanation of responses
- F1These unvested Restricted Stock Units were granted on February 19, 2015 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and become exercisable commencing one year after the grant date in four equal annual installments.
- F2This option was granted on February 19, 2015 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and becomes exercisable commencing one year after the grant date in four equal annual installments.